JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.
Thermo Fisher to shrink plasmid manufacturing lab in California, lay off 74 workers
Thermo Fisher is set to “adjust staffing levels” at a plasmid manufacturing laboratory in California, and the company is still exploring what to do with